These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34108037)

  • 1. Vasculitis damage index in Behçet's disease.
    Elgengehy FT; Gamal SM; Sobhy N; Siam I; Soliman AM; Elhady GW; Gheita TA
    Adv Rheumatol; 2021 Jun; 61(1):33. PubMed ID: 34108037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Damage accrual in Behçet disease: Behçet's Syndrome Overall Damage Index (BODI) versus Behçet's Disease Damage Index (BDI).
    Hassan RA; Abdelhady EI; Rabie M; Kamal DE
    Int J Rheum Dis; 2023 Jun; 26(6):1103-1110. PubMed ID: 37145347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity and reliability of the BODI for assessing damage in Behcet's disease.
    Musavian S; Farzaneh R; Rahimi M; Mahdavi AM; Gojazadeh M; Khabbazi A
    Ir J Med Sci; 2023 Oct; 192(5):2549-2553. PubMed ID: 36567419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
    Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a Behçet's Disease Damage Index for adults with BD: An Explicit, Composite and Rated (ECR) tool.
    Gheita TA; Hammam N; Fawzy SM; Abd El-Latif E; El-Gazzar II; Samy N; El-Hammady DH; Abdel Noor R; El-Shebini E; El-Najjar AR; Eesa NN; Salem MN; Ibrahim SE; El-Essawi DF; Elsaman AM; Senara S; Fathi HM; Sallam RA; El Shereef RR; Abd Elazeem MI; Fawzy RM; Khalil NM; Shahin D; El-Saadany HM; ElKhalifa M; Nasef SI; Abdalla AM; Noshy N; Said EA; Saad E; Moshrif AH; El-Shanawany AT; Abdel-Fattah YH; Raafat HA; Khalil HM;
    Int J Rheum Dis; 2021 Aug; 24(8):1071-1079. PubMed ID: 34288457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of pulse cyclophosphamide and azathioprine in ocular manifestations of Behcet's disease: longitudinal study of up to 10 years.
    Davatchi F; Sadeghi Abdollahi B; Shams H; Shahram F; Nadji A; Chams-Davatchi C; Faezi T; Akhlaghi M; Ghodsi Z; Ashofteh F; Mohtasham N
    Int J Rheum Dis; 2014 May; 17(4):444-52. PubMed ID: 24314325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Mean Platelet Volume in Patients With Behcet's Disease as an Indicator of Vascular Thrombosis.
    Ataş H; Canpolat F; Eskioglu F
    Arch Iran Med; 2018 Jun; 21(6):234-239. PubMed ID: 29940741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of Behçet's disease].
    Comarmond C; Wechsler B; Cacoub P; Saadoun D
    Rev Med Interne; 2014 Feb; 35(2):126-38. PubMed ID: 24438860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of treatment adherence in patients with Behçet's disease: its relation to disease manifestations, patients' beliefs about medications, and quality of life.
    Zayed HS; Medhat BM; Seif EM
    Clin Rheumatol; 2019 Mar; 38(3):761-768. PubMed ID: 30367312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of breast milk on Behçet's disease clinical features.
    Konak HE; Erden A; Armağan B; Güven SC; Apaydın H; Dağlı PA; Uzun Y; Kaygısız M; Küçükşahin O; Omma A
    Turk J Med Sci; 2023 Feb; 53(1):121-129. PubMed ID: 36945965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of neurological manifestations of Behçet's disease: a retrospective monocentric study in Tunisia.
    Houman MH; Bellakhal S; Ben Salem T; Hamzaoui A; Braham A; Lamloum M; Monia SK; Ben Ghorbel I
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2015-8. PubMed ID: 23830180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behçet's disease in Egypt: a multicenter nationwide study on 1526 adult patients and review of the literature.
    Gheita TA; El-Latif EA; El-Gazzar II; Samy N; Hammam N; Abdel Noor RA; El-Shebeiny E; El-Najjar AR; Eesa NN; Salem MN; Ibrahim SE; El-Essawi DF; Elsaman AM; Fathi HM; Sallam RA; El-Shereef RR; Abd-Elazeem MI; Said EA; Khalil NM; Shahin D; El-Saadany HM; ElKhalifa MS; Nasef SI; Abdalla AM; Noshy N; Fawzy RM; Saad E; Moshrif AH; El-Shanawany AT; Abdel-Fattah YH; Khalil HM;
    Clin Rheumatol; 2019 Sep; 38(9):2565-2575. PubMed ID: 31119493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rare but serious manifestation of Behçet's disease: intracardiac thrombus in 22 patients.
    Emmungil H; Yaşar Bilge NŞ; Küçükşahin O; Kılıç L; Okutucu S; Gücenmez S; Kalyoncu U; Kaşifoğlu T; Turgay M; Aksu K
    Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S87-92. PubMed ID: 25068833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of Life in Patients With Behçet Disease and Its Relation With Clinical Symptoms and Disease Activity.
    Khabbazi A; Ebrahimzadeh Attari V; Asghari Jafarabadi M; Malek Mahdavi A
    Reumatol Clin (Engl Ed); 2021 Jan; 17(1):1-6. PubMed ID: 31078452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of Angiopoietin-1 in Behcet's disease patients with vascular involvement.
    Bassyouni IH; Sharaf M; Wali IE; Mansour HM
    Heart Vessels; 2016 Jun; 31(6):918-24. PubMed ID: 25964071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frosted branch angiitis and cerebral venous sinus thrombosis as an initial onset of neuro-Behçet's disease: a case report and review of the literature.
    Ferreira BFA; Rodriguez EEC; Prado LLD; Gonçalves CR; Hirata CE; Yamamoto JH
    J Med Case Rep; 2017 Apr; 11(1):104. PubMed ID: 28410605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral venous sinus thrombosis in Behçet's disease: a retrospective case-control study.
    Shi J; Huang X; Li G; Wang L; Liu J; Xu Y; Zeng X; Zheng W
    Clin Rheumatol; 2018 Jan; 37(1):51-57. PubMed ID: 28612244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behcet's disease: epidemiology, clinical manifestations, and diagnosis.
    Davatchi F; Chams-Davatchi C; Shams H; Shahram F; Nadji A; Akhlaghi M; Faezi T; Ghodsi Z; Sadeghi Abdollahi B; Ashofteh F; Mohtasham N; Kavosi H; Masoumi M
    Expert Rev Clin Immunol; 2017 Jan; 13(1):57-65. PubMed ID: 27351485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could be serum uric acid a risk factor for thrombosis and/or uveitis in Behcet's disease?
    Atıl A; Deniz A
    Vascular; 2018 Aug; 26(4):378-386. PubMed ID: 29360007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose intravenous steroid pulse therapy in ocular involvement of Behcet's disease: a pilot double-blind controlled study.
    Mohammadi M; Shahram F; Shams H; Akhlaghi M; Ashofteh F; Davatchi F
    Int J Rheum Dis; 2017 Sep; 20(9):1269-1276. PubMed ID: 28524639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.